Literature DB >> 9383371

Synthetic calicheamicin mimics with novel initiation mechanisms: DNA cleavage, cytotoxicity, and apoptosis.

K C Nicolaou1, E N Pitsinos, E A Theodorakis, H Saimoto, W Wrasidlo.   

Abstract

BACKGROUND: Calicheamicin gamma 1I is a bacterial product that is a prominent member of the enediyne class of antitumor antibiotics, and has been extensively studied. Calicheamicin gamma 1I binds to DNA, causing double-stranded breaks, and cells exposed to it eventually become apoptotic. It can now be made synthetically, and highly potent biological mimics have been designed. Such molecules have many potential clinical applications, but are complex to make. We therefore investigated whether simplified versions of these molecules are biologically active.
RESULTS: We designed and synthesized a number of simple calicheamicin mimics and evaluated their biological activity. We also constructed mimics that are particularly suitable for conjugation to proteins, oligonucleotides, and other delivery systems. Several active mimics were found, and two in particular, which lack the trisulfide and oligosaccharide moieties of calicheamicin, had potent DNA-cleaving and cytotoxic activities. They caused chiefly single-stranded cuts in DNA, however, unlike the natural molecule, which causes double-stranded DNA cuts. Although they were able to induce apoptosis, they were less potent than the natural compound in this assay.
CONCLUSIONS: The simple enediyne mimics were less potent than calicheamicin gamma 1I, presumably because they lack the oligosaccharide DNA-binding domain. Nevertheless, considering their relatively primitive structures, they have remarkable biological properties. They may be useful biological tools and are potential leads for the development of chemotherapeutic agents. We propose that the ability of the enediynes to induce apoptosis is related to their ability to make double-stranded cuts in DNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9383371     DOI: 10.1016/1074-5521(94)90041-8

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  8 in total

Review 1.  Chemical approaches to control gene expression.

Authors:  J M Gottesfeld; J M Turner; P B Dervan
Journal:  Gene Expr       Date:  2000

Review 2.  Constructing molecular complexity and diversity: total synthesis of natural products of biological and medicinal importance.

Authors:  K C Nicolaou; Christopher R H Hale; Christian Nilewski; Heraklidia A Ioannidou
Journal:  Chem Soc Rev       Date:  2012-06-28       Impact factor: 54.564

Review 3.  Gemtuzumab ozogamicin.

Authors:  J K McGavin; C M Spencer
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia.

Authors:  Akihiro Takeshita
Journal:  Int J Hematol       Date:  2013-05-26       Impact factor: 2.490

5.  First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors.

Authors:  Ignacio Garrido-Laguna; Ian Krop; Howard A Burris; Erika Hamilton; Fadi Braiteh; Amy M Weise; Maysa Abu-Khalaf; Theresa L Werner; Steven Pirie-Shepherd; Christopher J Zopf; Mani Lakshminarayanan; Jaymes S Holland; Raffaele Baffa; David S Hong
Journal:  Int J Cancer       Date:  2019-02-23       Impact factor: 7.396

Review 6.  Fate of Antibody-Drug Conjugates in Cancer Cells.

Authors:  Cécile Chalouni; Sophia Doll
Journal:  J Exp Clin Cancer Res       Date:  2018-02-06

7.  Challenges and Opportunities to Develop Enediyne Natural Products as Payloads for Antibody-Drug Conjugates.

Authors:  Ajeeth Adhikari; Ben Shen; Christoph Rader
Journal:  Antib Ther       Date:  2021-01-12

8.  Draft Genome Sequence of Micromonospora sp. Strain WMMA1996, a Marine Sponge-Associated Bacterium.

Authors:  Doug R Braun; Marc G Chevrette; Deepa D Acharya; Cameron R Currie; Scott R Rajski; Tim S Bugni
Journal:  Genome Announc       Date:  2018-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.